A carregar...
Tumor Cell Recovery from Senescence Induced by Radiation with PARP Inhibition
Inhibitors of poly(ADP-ribose) polymerase (PARP) are clinically used as single-agent therapy for tumors with BRCA1 or BRCA2 mutations. One approach to expanding the use of PARP inhibitors to a wider range of tumors is to combine them with cytotoxic chemotherapy or radiotherapy. Preclinical studies i...
Na minha lista:
| Publicado no: | Radiat Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5094050/ https://ncbi.nlm.nih.gov/pubmed/27588595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR14437.1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|